Implementation and evaluation of health screening services to diabetic and hypertensive patients in a selected community pharmacy at belgaum city

Asian Journal of Pharmaceutical and Clinical Research

Volumn 8, Issue 3, 2015, Pages 305-315

  Sushilkumar, P L ^a,c   Mahendrakumar, B J ^b   Suman, Baishnab ^c   Gloria, Sam K ^c   Chaitanya, Kumar T ^c  

^a RK UNIVERSITY   (India)

^b Sri Adichunchanagiri College of Pharmacy   (India)

^c Bapuji College of Pharmacy   (India)

Author keywords

Community pharmacy; Diabetes; Health screening services; Hypertension

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COMMUNITY SAMPLE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATION; PHARMACIST; PHARMACY; PROSPECTIVE STUDY; PUBLIC HEALTH; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

EID: 84929071449     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wiedenmayer K, Summers RS, Mackie CA, Gous AG, Everard M. Developing Pharmacy Practice a Focus on Patient Care: Handbook. Geneva: World Health Organization; 2006. p. 3-6.
2. Health Screening. NTUC Income your partner for a better life. Available from: http://www.income.com.sg/enqform. [Last accessed on 2007 Oct 19].
3. Patil KV, Dharmalingam M, Kanakatte PK. Influence of socio-economic factors on diabetic care in India. International Diabetes Federation Congress. 18th Paris-France: Le Palais des Congres; 2003. p. 24-9.
4. The Royal Pharmaceutical Society of Great Britain. Practice Guidance on the Care of People with Diabetes. 3rd ed. Chichester, UK: Wiley & Sons Ltd.; 2004.
5. Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (home study). J Gen Intern Med 2005;20(12):1091-6.
6. McManus RJ, Mant J. Community pharmacies for detection and control of hypertension. J Hum Hypertens 2001;15(8):509-10.
7. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc (Wash) 2003;43(1):50-5.
8. Pharmacy-Based Hypertension Management Model: Protocol and Guidelines. CINDI/Euro Pharm Forum Project WHO Regional Office for Europe; 2004. p. 1-32.
9. Hersberger KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes-Evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 2006;28(3):171-9.
10. Improving Blood Pressure Management in Patients Diabetes: Available from: http://www.clinicaltrials.gov/ct. [Last accessed on 2007 Oct 19].
11. Moffat T. Point of care testing in a community pharmacy. Pharm J 2001;267:267-8.
12. Dugan BD. Enhancing community pharmacy through advanced pharmacy practice experiences. Am J Pharm Educ 2006;70(1):21.
13. Berger C. Screening of diabetes mellitus in burgandy. 18th International Diabetes Federation Congress, Paris, France; 2003. p. 24-9.
14. Tara Healthcare. Innovators in Irish Healthcare. Available from: http://www.tarahealth.com. [Last accessed on 2008 Nov]
15. The Royal Pharmaceutical Society of Great Britain. Diagnostic Testing in Community Pharmacy [Internet]. London. RPSGB. 2008. [cited on 2008]. Available from: http://www.rpharms.com/home/home.asp.
16. Harrison B, Hawksworth G, Hetherington L. Diagnostic testing and screening in community pharmacy. Pharm J 1992;249:226-37.
17. Lewis R, Jenkins C. A review of developments in diagnostic screening by community pharmacists. Community Pharm 2002;Vol. 12:34-5.